Patents/Assignees

Liposcience, Inc.

7 patents in portfolio

US12130295utility2024
NMR System and Methods for Multi-parameter Metabolic Vulnerability Index Evaluations
0 cites
US11988679utility2024
Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter
0 cites
US11990243utility2024
Multiple-marker Risk Parameters Predictive of Conversion to Diabetes
0 cites
US11942187utility2024
Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements
0 cites
US11782002utility2023
NMR Quantification of TMAO
0 cites
US11710568utility2023
Multi-parameter Diabetes Risk Evaluations
0 cites
US11703501utility2023
CHD Risk Stratification Evaluations for Subjects with High Levels of Large HDL-P
0 cites